Rozglyn MV 1mg/500mg/0.3mg Tablet
Marketer
Bilberry Pharmaceutical Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Rozglyn MV 1mg/500mg/0.3mg Tablet
Diabexa Trio (1mg/500mg/0.3mg) tablets are classified as antidiabetic agents, a combination medication for managing type 2 diabetes in adults. This formulation helps regulate blood glucose. Diabexa Trio should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and carry a fast-acting glucose source. Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. Diabexa Trio is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease before commencing treatment; pregnancy and breastfeeding require physician consultation. Regular blood glucose monitoring, along with blood tests to assess blood cell counts and liver function, are recommended.
Primary Ingredients of Rozglyn MV 1mg/500mg/0.3mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Rozglyn MV 1mg/500mg/0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Rozglyn MV 1mg/500mg/0.3mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The Rozglyn MV 1mg/500mg/0.3mg Tablet should be swallowed whole; do not chew, crush, or divide it. Administer on an empty stomach.
Common Side effects of Rozglyn MV 1mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Rozglyn MV 1mg/500mg/0.3mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Rozglyn MV 1mg/500mg/0.3mg Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Administer on an empty stomach.
How Rozglyn MV 1mg/500mg/0.3mg Tablet works:
Rozglyn MV tablets (1mg/500mg/0.3mg) contain a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Rozglyn MV 1mg/500mg/0.3mg Tablet with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Rozglyn MV 1mg/500mg/0.3mg Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against these risks prior to prescription. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Rozglyn MV 1mg/500mg/0.3mg Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Employing Rozglyn MV 1mg/500mg/0.3mg tablets in individuals with kidney impairment carries a substantial risk and is best avoided. Medical advice is strongly recommended. Furthermore, this medication is unsuitable for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Individuals with liver impairment should use Rozglyn MV 1mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. Medical advice is essential. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, its use is contraindicated in patients with severe liver dysfunction.
What if you forget to take Rozglyn MV 1mg/500mg/0.3mg Tablet :
Should you forget to take a Rozglyn MV 1mg/500mg/0.3mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Rozglyn MV 1mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Treatment |
3,018 People bought this recently